Ligand · 0Y5
0Y5 · 4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]methyl}-2-[3-(trifluoromethyl)phenoxy]benzoic acid
0Y5, 4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]methyl}-2-[3-(trifluoromethyl)phenoxy]benzoic acid (C25 H24 F3 N3 O5, 503.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry).…
- Component
- 0Y5
- Formula
- C25 H24 F3 N3 O5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0Y5 in 2 structures; the first of them:
- 4GSY · Crystal structure of thymidylate kinase from Staphylococcus aureus bound to inhibitor. · 0Y5 A301 · binds GLU37, PRO38, GLY44, ILE47, ARG48, VAL51, LEU52, LEU65 and 8 more
- 4GSY · Crystal structure of thymidylate kinase from staphylococcus aureus bound to inhibitor. · 0Y5 A301 · binds GLU37, PRO38, GLY44, ILE47, ARG48, VAL51, LEU52, LEU65 and 8 more
Residues it binds most
ARG 4, SER 4, LEU 4, TYR 4, GLN 4, GLU 4, GLY 4, ILE 4, PHE 4, PRO 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.